External Validation of Postoperative Nomograms for Prediction of All-Cause Mortality, Cancer-Specific Mortality, and Recurrence in Patients With Urothelial Carcinoma of the Bladder

European Urology - Tập 61 - Trang 58-64 - 2012
Philipp Nuhn1, Matthias May2, Maxine Sun3, Hans-Martin Fritsche4, Sabine Brookman-May4, Alexander Buchner1, Christian Bolenz5, Rudolf Moritz6, Edwin Herrmann6, Maximilian Burger4, Derya Tilki1, Lutz Trojan5, Paul Perrotte3, Axel Haferkamp7, Markus Hohenfellner8, Wolf F. Wieland4, Stefan C. Müller9, Pierre I. Karakiewicz3, Patrick J. Bastian1
1Department of Urology, Ludwig-Maximilians-Universität, Munich, Germany
2Department of Urology, Klinikum St. Elisabeth Straubing, Straubing, Germany
3Cancer Prognostics and Health Outcomes Unit, University of Montreal Health Center, Montreal, Québec, Canada
4Caritas-Krankenhaus St. Josef, University of Regensburg, Regensburg, Germany
5Mannheim Medical Center, University of Heidelberg, Mannheim, Germany
6Department of Urology, University of Münster, Münster, Germany
7Department of Urology, University of Frankfurt am Main, Frankfurt am Main, Germany
8Department of Urology, University of Heidelberg, Heidelberg, Germany
9Department of Urology, University of Bonn, Bonn, Germany

Tài liệu tham khảo

Stenzl, 2011, Treatment of muscle-invasive and metastatic bladder cancer: update of the EAU guidelines, Eur Urol, 59, 1009, 10.1016/j.eururo.2011.03.023 Nix, 2010, Prospective randomized controlled trial of robotic versus open radical cystectomy for bladder cancer: perioperative and pathologic results, Eur Urol, 57, 196, 10.1016/j.eururo.2009.10.024 Challacombe BJ, Bochner BH, Dasgupta P, et al. The role of laparoscopic and robotic cystectomy in the management of muscle-invasive bladder cancer with special emphasis on cancer control and complications. Eur Urol. In press. DOI:10.1016/j.eururo.2011.05.012. Hayn, 2011, Defining morbidity of robot-assisted radical cystectomy using a standardized reporting methodology, Eur Urol, 59, 213, 10.1016/j.eururo.2010.10.044 Lawrentschuk, 2010, Prevention and management of complications following radical cystectomy for bladder cancer, Eur Urol, 57, 983, 10.1016/j.eururo.2010.02.024 Maffezzini, 2010, Re: urinary diversion and morbidity after radical cystectomy for bladder cancer, Eur Urol, 57, 1116, 10.1016/j.eururo.2010.03.023 Gore, 2010, Urinary diversion and morbidity after radical cystectomy for bladder cancer, Cancer, 116, 331, 10.1002/cncr.24763 Shariat, 2006, Outcomes of radical cystectomy for transitional cell carcinoma of the bladder: a contemporary series from the Bladder Cancer Research Consortium, J Urol, 176, 2414, 10.1016/j.juro.2006.08.004 Dalbagni, 2001, Cystectomy for bladder cancer: a contemporary series, J Urol, 165, 1111, 10.1016/S0022-5347(05)66440-3 Stein, 2001, Radical cystectomy in the treatment of invasive bladder cancer: long-term results in 1,054 patients, J Clin Oncol, 19, 666, 10.1200/JCO.2001.19.3.666 Madersbacher, 2003, Radical cystectomy for bladder cancer today—a homogeneous series without neoadjuvant therapy, J Clin Oncol, 21, 690, 10.1200/JCO.2003.05.101 Dalbagni, 2009, Clinical outcome in a contemporary series of restaged patients with clinical T1 bladder cancer, Eur Urol, 56, 903, 10.1016/j.eururo.2009.07.005 Feifer, 2011, Maximizing cure for muscle-invasive bladder cancer: integration of surgery and chemotherapy, Eur Urol, 59, 978, 10.1016/j.eururo.2011.01.014 Shariat, 2008, Nomograms for bladder cancer, Eur Urol, 54, 41, 10.1016/j.eururo.2008.01.004 Karakiewicz, 2006, Nomogram for predicting disease recurrence after radical cystectomy for transitional cell carcinoma of the bladder, J Urol, 176, 1354, 10.1016/j.juro.2006.06.025 Bochner, 2006, Postoperative nomogram predicting risk of recurrence after radical cystectomy for bladder cancer, J Clin Oncol, 24, 3967, 10.1200/JCO.2005.05.3884 Shariat, 2006, Nomograms provide improved accuracy for predicting survival after radical cystectomy, Clin Cancer Res, 12, 6663, 10.1158/1078-0432.CCR-06-0372 Steyerberg, 2003, Internal and external validation of predictive models: a simulation study of bias and precision in small samples, J Clin Epidemiol, 56, 441, 10.1016/S0895-4356(03)00047-7 Stenzl, 2009, The updated EAU guidelines on muscle-invasive and metastatic bladder cancer, Eur Urol, 55, 815, 10.1016/j.eururo.2009.01.002 Harrell, 1996, Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors, Stat Med, 15, 361, 10.1002/(SICI)1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO;2-4 DeLong, 1988, Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach, Biometrics, 44, 837, 10.2307/2531595 Vickers, 2006, Decision curve analysis: a novel method for evaluating prediction models, Med Decis Making, 26, 565, 10.1177/0272989X06295361 Herr, 2004, Surgical factors influence bladder cancer outcomes: a cooperative group report, J Clin Oncol, 22, 2781, 10.1200/JCO.2004.11.024 Elstein, 1999, Heuristics and biases: selected errors in clinical reasoning, Acad Med, 74, 791, 10.1097/00001888-199907000-00012 Vlaev, 2006, Game relativity: how context influences strategic decision making, J Exp Psychol Learn Mem Cogn, 32, 131, 10.1037/0278-7393.32.1.131 Kattan, 2002, Nomograms. Introduction, Semin Urol Oncol, 20, 79 Hogarth, 2007, Heuristic and linear models of judgment: matching rules and environments, Psychol Rev, 114, 733, 10.1037/0033-295X.114.3.733 Zaak, 2010, Predicting individual outcomes after radical cystectomy: an external validation of current nomograms, BJU Int, 106, 342, 10.1111/j.1464-410X.2009.09138.x May, 2011, Association between the number of dissected lymph nodes during pelvic lymphadenectomy and cancer-specific survival in patients with lymph node-negative urothelial carcinoma of the bladder undergoing radical cystectomy, Ann Surg Oncol, 18, 2018, 10.1245/s10434-010-1538-6 May, 2011, Lymph node density affects cancer-specific survival in patients with lymph node–positive urothelial bladder cancer following radical cystectomy, Eur Urol, 59, 712, 10.1016/j.eururo.2011.01.030 Kramer, 2010, HYAL-1 hyaluronidase: a potential prognostic indicator for progression to muscle invasion and recurrence in bladder cancer, Eur Urol, 57, 86, 10.1016/j.eururo.2009.03.057 Shariat, 2010, Combination of multiple molecular markers can improve prognostication in patients with locally advanced and lymph node positive bladder cancer, J Urol, 183, 68, 10.1016/j.juro.2009.08.115 Shariat, 2010, Association of angiogenesis related markers with bladder cancer outcomes and other molecular markers, J Urol, 183, 1744, 10.1016/j.juro.2010.01.018